The addition of Retatrutide, which improves insulin sensitivity through GLP-1 and GIP pathways, likely offsets any mild glucose-raising effect from Tesamorelin
FDA Enforcement, Hims & Hers Pullback, Novo Nordisk GLP-1 Lawsuit, Weight-Loss Telehealth Warnings On February 6, 2026 , the U.S
M-F 9am-9pm
At Town & Country Compounding , we are proud to be in the top 1% of compounding pharmacies in the United States, thanks to our industry-leading accreditations and commitment to patient care
Retatrutide produces the most significant weight loss of any pharmaceutical intervention currently in clinical trials, with participants losing an average of 24.2% of their body weight over 48 weeks at the highest dose
Call/Text 312.312.7873 or Book an Appointment Online